Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Covington
Teva
Boehringer Ingelheim
Harvard Business School
Fuji
Mallinckrodt
Fish and Richardson

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,889,052

« Back to Dashboard

Summary for Patent: 5,889,052
Title: Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
Abstract:Disclosed is the use of cloprostenol and fluprostenol analogues for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
Inventor(s): Klimko; Peter G. (Fort Worth, TX), Bishop; John E. (Groton, MA), Sallee; Verney L. (Burleson, TX), Zinke; Paul W. (Fort Worth, TX)
Assignee: Alcon Laboraties, Inc. (Fort Worth, TX)
Application Number:08/917,795
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,889,052
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 5,889,052

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,889,052

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hong Kong 1072716 ➤ Try a Free Trial
European Patent Office 0639563 ➤ Try a Free Trial
European Patent Office 1514548 ➤ Try a Free Trial C300671 Netherlands ➤ Try a Free Trial
European Patent Office 1514548 ➤ Try a Free Trial PA2014029 Lithuania ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Express Scripts
Julphar
Cerilliant
Argus Health
Teva
Daiichi Sankyo
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.